bighatbiosciences
BigHat Biosciences seeks a hands‑on, bench‑driven scientist to perform IND‑enabling developability assessments on late‑stage drug candidates for their AI‑designed therapeutics platform. The 12‑month contract role focuses on executing complex stability studies and analytical method development in a laboratory setting.
Headquarters
San Mateo, California, United States
Company Size
51-200 employees
Founded
2019
BigHat Biosciences is a San Mateo-based biotechnology company that uses a machine-learning-guided Milliner platform to accelerate full-stack antibody discovery and engineering. It combines a synthetic biology-enabled wet lab with AI-driven design to create safer, more effective biologic therapies. The company pursues wholly-owned and partnered antibody programs and collaborates with industry partners to advance biologics discovery and development.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for bighatbiosciences.
bighatbiosciences didn’t post a salary, so this is our estimate from similar listings.
3% below the average for this role
Associate Scientist II, Biologics Drug Product Development
AbbVie
Director, Analytical Sciences
Spyre Therapeutics
Scientist III - Analytical Chemistry and Molecular Biology - FSP
Parexel
Associate Scientist II, Biologics Drug Product Development
AbbVie
CGT- Biologics HPLC Scientist
Eurofins
Advisor - Analytical Development CMC
Eli Lilly and Company